Despiramine in the treatment of drug-resistant malarial infections
US5373005A · kind A · utility
3Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 1993 |
| Grant date | Dec 13, 1994 |
| Priority date | — |
| Expiry date | Mar 5, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Drug-resistant malarial infection in humans can be effectively treated with standard antimalarial agents if administered in conjunction with desipramine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.